Myocarditis Following mRNA COVID-19 Vaccine
Timothy Visclosky, Nik Theyyunni, Nicole Klekowski, Stuart Bradin
Abstract
ABSTRACT: A growing number of adolescents are being diagnosed with acute myocarditis following mRNA COVID-19 vaccinations. This case describes an adolescent who presented to the emergency department with chest pain and tachycardia following the Pfizer-BioNTech COVID-19 vaccination. Point-of-care ultrasound was performed prior to the return of laboratory studies and revealed depressed left ventricular systolic function. Point-of-care ultrasound may be a tool used to rapidly diagnose or risk stratify patients with potential post-COVID-19 vaccine myocarditis.
Topics & Concepts
MedicineMyocarditisAcute myocarditisCardiologyVentricular tachycardiaInternal medicineEmergency departmentUltrasoundChest painTachycardiaImmunologyElectrocardiographyHeart diseaseViral MyocarditisMessenger RNAAntibodyIntensive careViral diseaseYoung adultComplicationUltrasound in Clinical ApplicationsViral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 Research